Nilotinib

Common brands: Tasigna, Danziten, Sprycel, Imatinib Mesylate, Imatinib

Top reporter: Novartis Pharmaceuticals Corporation

Kinase Inhibitor [EPC]Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]HMG-CoA Reductase Inhibitor [EPC]Proton Pump Inhibitor [EPC]
29,115
Total Reports
10,771
Serious Reports
5,585
Death Reports
30
Reported Reactions
Death Report Ratio: High (19.18%)

Patient Demographics

Male
13,843
Female
12,529

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Nilotinib.

# Reaction Reports % of Total
1 DEATH 3,216
9.6%
2 FATIGUE 2,094
6.2%
3 RASH 1,644
4.9%
4 NAUSEA 1,527
4.6%
5 HEADACHE 1,474
4.4%
6 DYSPNOEA 1,373
4.1%
7 PAIN 1,336
4.0%
8 DIARRHOEA 1,204
3.6%
9 DRUG INEFFECTIVE 1,190
3.6%
10 PRURITUS 1,128
3.4%
11 MALAISE 1,126
3.4%
12 PYREXIA 1,124
3.4%
13 ARTHRALGIA 1,067
3.2%
14 ASTHENIA 1,046
3.1%
15 VOMITING 1,046
3.1%
16 DIZZINESS 907
2.7%
17 MYOCARDIAL INFARCTION 888
2.6%
18 PAIN IN EXTREMITY 862
2.6%
19 MYALGIA 825
2.5%
20 PLATELET COUNT DECREASED 824
2.5%
21 CHRONIC MYELOID LEUKAEMIA 823
2.5%
22 ABDOMINAL PAIN 806
2.4%
23 ABDOMINAL PAIN UPPER 788
2.4%
24 DRUG INTOLERANCE 773
2.3%
25 PLEURAL EFFUSION 772
2.3%
26 ANAEMIA 768
2.3%
27 COUGH 740
2.2%
28 DECREASED APPETITE 719
2.1%
29 MALIGNANT NEOPLASM PROGRESSION 719
2.1%
30 ELECTROCARDIOGRAM QT PROLONGED 711
2.1%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.